SCHEMBL6186026

SCHEMBL6186026

[2H]c1c([2H])c([2H])c(-c2ccc(C(C)C(=O)OCC)cc2F)c([2H])c1[2H]

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTGS2 P35354 7/20 0.52
PTGS1 P23219 5/20 0.48
APP P05067 4/20 0.48
PGR P06401 1/20 0.48
PDE4A P27815 1/20 0.48
AKR1C3 P42330 4/20 0.48
AKR1C2 P52895 4/20 0.48
CYP2C19 P33261 3/20 0.48
MEN1 O00255 2/20 0.48
KMT2A Q03164 2/20 0.48
CYP2C9 P11712 2/20 0.48
PSEN1 P49768 2/20 0.48
PSEN2 P49810 2/20 0.48
APH1B Q8WW43 2/20 0.48
NCSTN Q92542 2/20 0.48
APH1A Q96BI3 2/20 0.48
PSENEN Q9NZ42 2/20 0.48
FABP2 P12104 1/20 0.48
TSHR P16473 1/20 0.48
AKR1C4 P17516 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31456322 0.83 PTGS2 (0.70) PTGS2PTGS1APPPGRPDE4A
SCHEMBL8755060 0.83 PTGS2 (0.70) PTGS2PTGS1APPPGRPDE4A
SCHEMBL9555720 0.83 PTGS2 (0.70) PTGS2PTGS1APPPGRPDE4A
SCHEMBL17918662 0.83 PTGS2 (0.70) PTGS2PTGS1APPPGRPDE4A
Flurbiprofen SCHEMBL6189005 0.83 AKR1C3 (0.69) PTGS2PTGS1APPAKR1C3AKR1C2
SCHEMBL8189912 0.80 CYP2C19 (0.73) PTGS2PTGS1APPPGRPDE4A
SCHEMBL24875595 0.77 PTGS2 (0.44) PTGS2PTGS1APPPGRPDE4A
SCHEMBL11738925 0.77 PTGS2 (0.47) PTGS2PTGS1APPPGRPDE4A
SCHEMBL5948065 0.74 PTGS2 (0.44) PTGS2PTGS1APPPGRPDE4A
SCHEMBL2011901 0.74 APP (0.48) PTGS2PTGS1APPPGRPDE4A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0979226-B1 ISOXAZOLE DERIVATIVES SUMITOMO PHARMA (JP) 2005-11-09 EP disclosed
US-6100260-A ((3-(1-(2-FLUORO-BIPHENYL-4-YL)-ETHYL)-ISOXAZOL-5-YLIMINO) -MORPHOLIN-4-YL-M ETHYL)-AMINE, FOR EXAMPLE; ADMINISTERING TO TREAT AUTOIMMUNE DISEASES AND INFLAMMATION SUMITOMO PHARMACEUTICAL COMPANY, LIMITED (JP) 2000-08-08 US disclosed